NSE - SMEListed
Aristo Bio-Tech and Lifescience Limited
Company websiteAristo Bio-Tech and Lifescience Limited plans to raise ₹18,12,800 crore via IPO. That includes a fresh infusion of ₹18,12,800 crore and an OFS worth ₹0 crore.
Apply from 16-01-2023 until 19-01-2023. Allotment and tentative listing are scheduled for 25-01-2023 and 30-01-2023. Quick tip: check lot size and valuation before bidding.
Start Date16-01-2023
End Date19-01-2023
Listing Date30-01-2023
Allotment Date25-01-2023
Current Price₹80
GMP₹43 (59.72%)
Lot Size1600 Shares
Subscription217.72 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹72 - ₹72
Pre Issue₹49,95,000
Post Issue₹68,07,800
Issue Size₹18,12,800
(aggregating up to 13.05 Cr)
(aggregating up to 13.05 Cr)
Fresh Issue₹18,12,800
(aggregating up to 13.05 Cr)
(aggregating up to 13.05 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Aristo Bio-Tech and Lifescience Limited is currently around ₹43 (59.72%). This indicates an estimated listing price of approximately ₹115 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
13 Nov 2025, 06:45 | ₹72 | ₹43 | ₹115 (59.72%) |
24 Mar 2025, 11:19 | ₹72 | ₹43 | ₹115 (59.72%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Aristo Bio-Tech and Lifescience Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Values |
|---|---|
EPS | 0 |
ROE | 0 |
ROCE | 0 |
RONW | 0 |
PRE IPO(PE) | 9.46 |
POST IPO(PE) | 0 |
The IPO reservation for Aristo Bio-Tech and Lifescience Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Market Maker | 5.03% | 91,200 |
NII (HNI) | 47.48% | 8,60,800 |
RETAIL | 47.48% | 8,60,800 |
TOTAL | 100.00% | 18,12,800 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,600 | ₹1,15,200 | |
HNI | 2 | 3,200 | ₹2,30,400 |
Below you can find the official contact details of Aristo Bio-Tech and Lifescience Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@aristobiotech.com
Phone: +91-2667-264843
Website: http://www.aristobiotech.com/
Address: E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara – 391775